[1]李泰贤 陈志伟 王荣田 陈卫衡△.基于文献计量学分析中医药治疗股骨头坏死的研究现状[J].中国中医骨伤科杂志,2017,25(04):41-46.
　LI Taixian CHEN Zhiwei WANG Rongtian CHEN Weiheng.The Research Status of Traditional Chinese Medicine Treatment for Osteonecrosis of Femoral Head Based on Bibliometric Analysis[J].Chinese Journal of Traditional Medical Traumatology & Orthopedics,2017,25(04):41-46.
点击复制

基于文献计量学分析中医药治疗股骨头坏死的研究现状()
分享到：

《中国中医骨伤科杂志》[ISSN:1005-0205/CN:42-1340/R]

卷:
第25卷
期数:
2017年04期
页码:
41-46
栏目:
文献研究
出版日期:
2017-04-06

文章信息/Info

Title:
The Research Status of Traditional Chinese Medicine Treatment for Osteonecrosis of Femoral Head Based on Bibliometric Analysis
文章编号:
1005-0205(2017)04-0041-06
作者:
李泰贤1 陈志伟1 王荣田1 陈卫衡1△
1.中国中医科学院望京医院(北京,100102)
△.通信作者 E-mail:drchenweiheng@163.com
Author(s):
LI Taixian1 CHEN Zhiwei1 WANG Rongtian1 CHEN Weiheng1△
1.Wangjing Hospital of China Academy of Chinese Medical Sciences,Beijing 100102,China.
关键词:
股骨头坏死;  中医药;  文献计量学
Keywords:
osteonecrosis of the femoral head;  traditional chinese medicine;  bibliometrics analysis
分类号:
R274.39
文献标志码:
A
摘要:
目的:采用文献计量学方法分析中医药治疗股骨头坏死的研究现状,揭示研究动态变化和发展态势,为中医治疗股骨头坏死的临床、教学、科研人员提供定性、定量的参考信息。方法:检索1989年4月2日至2015年12月31日期间在三大数据库(中国知识资源总库(CNKI)、万方数据知识服务平台、PubMed)中公开发表的关于中医药治疗股骨头坏死的文献,分析分布年代、文献类型及语言、作者分布、核心机构、期刊分布、高频关键词、证型以及方剂等特点。结果:纳入文献共计1 297篇,2010至2015年6年共发表695篇论文,占全部论文量的53.58%,论文数量总体呈逐年上升趋势,是中医药治疗股骨头坏死热点时期,且文献以中文期刊类论文为主; 何伟、陈卫衡论文发表构成比为5.78%和4.16%,明显高于其他作者; 广州中医药大学、中国中医科学院发文量构成比为10.87%和5.39%,高于其他机构; 《中国中医骨伤科杂志》、《中医正骨》、《光明中医》、《中国骨伤》杂志的载文量分别为3.54%,2.69%,1.54%,1.46%,高于其他期刊; 中药、激素、疗效、中西医等为出现频率最高的关键词; 气滞血瘀证、肝肾亏虚证、痰瘀阻络证、经脉痹阻证等为中药治疗股骨头坏死的常用证型; 桃红四物汤、独活寄生汤、补阳还五汤、通络生骨胶囊等为中药治疗股骨头坏死的常用方剂及中成药。结论:近6年为中医药治疗股骨头坏死研究热点时期,且吸引了较多的研究者,但研究机构较为集中,多数研究以临床研究为主,基础研究较少。疗效评价缺乏统一的标准、证型使用欠规范仍是需要进一步研究与解决的难题。
Abstract:
Objective:To analysis the research status of traditional Chinese medicine treatment for osteonecrosis of femoral head based on literature analysis,and provides reference for researchers.Methods:The literature about TCM treatment for osteonecrosis of femoral head was retrieved from PubMed,CNKI and Wanfang Database.Methology analysis was conducted from the aspects of publication time,literature type and language,author distribution,publication institution,journals distribution,high-frequency,type of syndrome and prescriptions.Results:Totally 1 297 articles were considered to be eligible for inclusion.2010～2015 was hot-period of TCM treatment for osteonecrosis of femoral head,during this period 695 articles were published,and the articles of this period make up 53.58% of all the articles.The number of articles was on the rise.Literature mainly is Chinese periodical literature; scholars like He Wei and CHEN Wei-heng were more productive than other scholars,amounting 5.78% and 4.16% respectively.Guangzhou University of TCM,China Academy of Chinese Medical Sciences published more articles than other universities or research institute,amounting 10.87% and 5.39% respectively.Chinese Journal of Traditional Medical Traumatology & Orthopedics,the Journal of Traditional Chinese Orthopedics and Traumatology,Guangming Journal of Chinese Medicine and Chinese Journal of Traditional Medical Traumatology & Orthopedics published more articles than other periodical,amounting 3.54%,2.69%,1.54% and 1.46% respectively.Herbal,steroid,efficacy and integrative medicine therapy are the most high frequency of occurrence keyword.Recent research concentrates on Chinese medicine experimental and clinical study,followed by traditional Chinese medicine therapy,traditional Chinese and western medicine therapy.Stagnation of Qi and blood stasis syndrome,liver and kidney deficiency syndrome,phlegm-stasis in channels are the most commonly-used type of syndrome.Taohong Siwu Decoction,Duhuo Jisheng decoction,Buyang Huanwu Decoction and Tongluoshenggu Capsule are the most commonly-used prescriptions.Conclusion:The research on traditional Chinese medicine treatment for osteonecrosis of femoral head become a hot area in last five years,had attracted more scholars'attention.But,we should face the problems,such as research institutions were too concentrated,most research is clinical research,fewer fundamental research,lack of unified curative effect evaluation standard,non-standard usage of type of syndrome,that need further research and resolutions.

参考文献/References:

[1] 李子荣.科学诊断和治疗股骨头坏死[J].中国修复重建外科杂志,2005,19(9):685-686.
[2] 中华医学会骨科分会显微修复学组,中国修复重建外科专业委员会骨缺损及骨坏死学组.成人股骨头坏死诊疗标准专家共识(2012 年版)[J].中华骨科杂志,2012,32(6):606-610.
[3] Meho L I,Yang K.Impact of data sources on citation counts and rankings of LIS faculty:Web of science versus scopus and google scholar[J].Journal of the American Society for Information Science & Technology,2007,58(13):2105-2125.
[4] 中华医学会骨科学分会关节外科学组.股骨头坏死临床诊疗规范[J].中国矫形外科杂志,2016,24(1):49-54.
[5] 何海军,陈卫衡,王荣田,等.股骨头坏死患者生存质量评价及多途径中药治疗临床研究[J].中国中医骨伤科杂志,2010,18(10):13-15.
[6] 郑超,郑秋坚,林帧,等.缺血性股骨头坏死的治疗进展[J].实用骨科杂志,2014,20(1):43-47.
[7] 贾晓军,欧志学,庞智晖,等.中药加微创减压复合植骨内稳定术对非创伤性股骨头坏死疼痛干预临床研究[J].新中医,2011(8):64-66.
[8] 陈曦,敬胜伟,秦明芳,等.2007～2009年度《中国中医骨伤科杂志》骨伤方剂分析[J].中国中医骨伤科杂志,2012(6):7-8.
[9] 陈卫衡,周宇,何海军,等.健脾活骨方治疗早中期非创伤性股骨头坏死临床回顾性研究[J].中国中西医结合杂志,2013,33(8):1054-1058.
[10] 陈卫衡,周宇,何海军,等.健脾活骨方治疗早中期非创伤性股骨头坏死的前瞻性临床研究[J].中华关节外科杂志:电子版,2013,7(3):3-8.
[11] 谢庆华,吴昭克,庄至坤,等.中医辨证治疗股骨头缺血性坏死240例疗效观察[J].中国中医骨伤科杂志,2012,20(3):24-25.
[12] 张斌山,李燕萍,陈绰雅.中医治疗创伤性股骨头坏死34例临床分析[J].中国医药科学,2012,2(8):57.
[13] 陈卫衡,张磊,刘道兵,等.联合微创手术治疗股骨头坏死的临床研究[J].中国矫形外科杂志,2004,12(17):1287-1289.
[14] Tang WM,Chiu KY.Avascular necrosis of femoral head:a short review[J].International Journal of Rheumatic Diseases,2006,9(1):98-101.
[15] 王荣田,陈卫衡,林娜,等.股骨头坏死的病因构成及发病特征分析[J].中国骨与关节损伤杂志,2009,24(9):792-795.
[16] 赵海燕,夏亚一,康鹏德.股骨头坏死病因与发病机制研究进展[J].中国矫形外科杂志,2009,17(8):604-607.
[17] 何维英,许超,季卫锋.骨健口服液治疗股骨头缺血性坏死106例临床报告[J].中国中医骨伤科杂志,2004,12(4):42-43.
[18] 邓敦,邓国荣.邓氏骨伤科膏药治疗股骨头坏死的临床研究[J].中国中医骨伤科杂志,2006(S2):63-66.
[19] 曾平,何伟,韦标方.复方生脉成骨胶囊治疗塌陷前期非创伤性股骨头坏死的临床研究[J].中国中医骨伤科杂志,2010,17(2):14-17.
[20] 韦标方,宋祥平,曾平,等.祛痰法治疗激素性股骨头坏死89例疗效分析[J].中国中医骨伤科杂志,2010,17(11):12-13.
[21] 乔美莲.针灸治疗激素性股骨头坏死[J].山西中医学院学报,2003,4(2):34-34.
[22] 程永.髀枢痹(股骨头坏死)中医病理关键环节与针灸治法探讨[J].辽宁中医药大学学报,2013,5(3):125-128.
[23] 滕居赞,苏波,王大伟.补肾活血汤加减联合雷火灸治疗股骨头缺血性坏死30例临床观察[J].河北中医,2013,35(4):491-493.
[24] 陈春香.针药联合治疗股骨头坏死的疗效观察[J].光明中医,2012,27(7):1398-1399.
[25] 张建福,张董喆,孔超,等.水针刀结合中药内服治疗股骨头无菌性坏死34例[J].河南中医,2013,33(11):1978-1979.
[26] 郭胜男,韦标方.中药内服联合针刀治疗早期股骨头坏死[J].光明中医,2015,30(3):552-553.
[27] 王钦敏,王勇,吕东,等.水针刀合通经方治疗股骨头无菌性坏死症32例[J].福建中医药大学学报,2014,24(5):53-54.
[28] 孙国辉,董晓俊,覃剑,等.中药配合小针刀治疗股骨头缺血性坏死的临床观察[J].中国中医骨伤科杂志,2007,15(10):42-43.
[29] 鲍自立,孙宣.中药结合小针刀治疗股骨头坏死的临床观察[J].中国中医骨伤科杂志,2013,21(3):45-46.
[30] 国家中医药管理局.中医病证诊断疗效标准[M].南京:南京大学出版社,1994:193,200-201.
[31] 卫生部.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002:354.
[32] 陈卫衡,刘道兵,张洪美,等.股骨头坏死的三期四型辨证思路[J].中国中医基础医学杂志,2003,9(12):51-52.
[33] 陈雷雷,何伟,张庆文,等.中医药治疗股骨头坏死临床试验的系统评价[J].中华中医药杂志,2012,27(3):710-715.

备注/Memo

备注/Memo:
基金项目:北京市科学技术委员会G20工程支撑保障“十病 十药”研发项目(Z151100003815028)
更新日期/Last Update: 2017-04-07